Boeing Gets an Upgrade, Moderna Wins FDA Vaccine Approval

On this episode of Stock Movers:
- Boeing (BA) shares gain after BofA Global Research upgraded the planemaker to buy from neutral, with analyst Ronald Epstein writing that company’s “aircraft emerged as the favored trade tool for the Trump administration in recent trade deals.”
- Moderna (MRNA) shares rise after the drugmaker won FDA approval for its second-generation Covid vaccine for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease.

See omnystudio.com/listener for privacy information.